相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Monitoring polysorbate hydrolysis in therapeutic proteins using an ultrasensitive extraction-free fatty acid quantitation method
Sisi Zhang et al.
ANALYTICAL BIOCHEMISTRY (2022)
Mechanistic understanding of metal-catalyzed oxidation of polysorbate 80 and monoclonal antibody in biotherapeutic formulations
Fethi Bensaid et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)
A Mechanistic Understanding of Monoclonal Antibody Interfacial Protection by Hydrolytically Degraded Polysorbate 20 and 80 under IV Bag Conditions
Aadithya Kannan et al.
PHARMACEUTICAL RESEARCH (2022)
Surface Tension and Self-association Properties of Aqueous Polysorbate 20 HP and 80 HP Solutions: Insights into Protein Stabilisation Mechanisms
Patrick Garidel et al.
JOURNAL OF PHARMACEUTICAL INNOVATION (2021)
High-Throughput, Fluorescence-Based Esterase Activity Assay for Assessing Polysorbate Degradation Risk during Biopharmaceutical Development
Adithi C. Bhargava et al.
PHARMACEUTICAL RESEARCH (2021)
A Comprehensive Assessment of All-Oleate Polysorbate 80: Free Fatty Acid Particle Formation, Interfacial Protection and Oxidative Degradation
Nidhi Doshi et al.
PHARMACEUTICAL RESEARCH (2021)
Complex Micellization Behavior of the Polysorbates Tween 20 and Tween 80
Hannah Knoch et al.
MOLECULAR PHARMACEUTICS (2021)
Comparison of Polysorbate 80 Hydrolysis and Oxidation on the Aggregation of a Monoclonal Antibody
Nicholas R. Larson et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Acidic and alkaline hydrolysis of polysorbates under aqueous conditions: Towards understanding polysorbate degradation in biopharmaceutical formulations
Mridula Dwivedi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Micellar Morphology of Polysorbate 20 and 80 and Their Ester Fractions in Solution via Small-Angle Neutron Scattering
Jannatun Nayem et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Rational design to biologics development: The polysorbates point of view
Ema Valentina Brovc et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability
Anthony Tomlinson et al.
MOLECULAR PHARMACEUTICS (2020)
Development and validation of a selective marker-based quantification of polysorbate 20 in biopharmaceutical formulations using UPLC QDa detection
Dirk-Heinrich Evers et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2020)
Micelle Driven Oxidation Mechansim and Novel Oxidation Markers for Different Grades of Polysorbate 20 and 80
Wendelin Kranz et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Rapid Polysorbate 80 Degradation by Liver Carboxylesterase in a Monoclonal Antibody Formulated Drug Substance at Early Stage Development
Sisi Zhang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Measuring Lipolytic Activity to Support Process Improvements to Manage Lipase-Mediated Polysorbate Degradation
Michael Jahn et al.
PHARMACEUTICAL RESEARCH (2020)
Factors Influencing Polysorbate's Sensitivity Against Enzymatic Hydrolysis and Oxidative Degradation
Wendelin Kranz et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Experience with Host Cell Protein Impurities in Biopharmaceuticals
Martin Vanderlaan et al.
BIOTECHNOLOGY PROGRESS (2018)
Considerations for the Use of Polysorbates in Biopharmaceuticals
Michael T. Jones et al.
PHARMACEUTICAL RESEARCH (2018)
Polysorbate degradation in biotherapeutic formulations: Identification and discussion of current root causes
Mridula Dwivedi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations
Josephine Chiu et al.
BIOTECHNOLOGY AND BIOENGINEERING (2017)
Impact of mono- and poly-ester fractions on polysorbate quantitation using mixed-mode HPLC-CAD/ELSD and the fluorescence micelle assay
Steffen Lippold et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2017)
Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy
Surinder M. Singh et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Molecular simulations of micellar aggregation of polysorbate 20 ester fractions and their interaction with N-phenyl-1-naphthylamine dye
Mauro Lapelosa et al.
BIOPHYSICAL CHEMISTRY (2016)
Polysorbates 20 and 80 Degradation by Group XV Lysosomal Phospholipase A2 Isomer X1 in Monoclonal Antibody Formulations
Troii Hall et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis
Vincent Corvari et al.
BIOLOGICALS (2015)
Key interactions of surfactants in therapeutic protein formulations: A review
Tank A. Khan et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Surfactant Effects on Particle Generation in Antibody Formulations in Pre-filled Syringes
Alana Gerhardt et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy
Linda O. Narhi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Understanding Particle Formation: Solubility of Free Fatty Acids as Polysorbate 20 Degradation Byproducts in Therapeutic Monoclonal Antibody Formulations
Nidhi Doshi et al.
MOLECULAR PHARMACEUTICS (2015)
Ester Hydrolysis of Polysorbate 80 in mAb Drug Product: Evidence in Support of the Hypothesized Risk After the Observation of Visible Particulate in mAb Formulations
Steven R. LaBrenz
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Protein Aggregation and Particle Formation in Prefilled Glass Syringes
Alana Gerhardt et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
IgG1 aggregation and particle formation induced by silicone-water interfaces on siliconized borosilicate glass beads: A model for siliconized primary containers
Pinaki Basu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Select host cell proteins coelute with monoclonal antibodies in protein a chromatography
Bartek Nogal et al.
BIOTECHNOLOGY PROGRESS (2012)
Excipient effects on humanized monoclonal antibody interactions with silicone oil emulsions
Keith A. Britt et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Immunogenicity of recombinant human interferon beta interacting with particles of glass, metal, and polystyrene
Miranda M. C. Van Beers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Mixed-mode and reversed-phase liquid chromatography-tandem mass spectrometry methodologies to study composition and base hydrolysis of polysorbate 20 and 80
Daniel Hewitt et al.
JOURNAL OF CHROMATOGRAPHY A (2011)
Effects of Surfaces and Leachables on the Stability of Biopharmaceuticals
Jared S. Bee et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
The Degradation of Polysorbates 20 and 80 and its Potential Impact on the Stability of Biotherapeutics
Ravuri S. K. Kishore et al.
PHARMACEUTICAL RESEARCH (2011)
Protein Adsorption and Excipient Effects on Kinetic Stability of Silicone Oil Emulsions
D. Brett Ludwig et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
A thermodynamic analysis of the binding interaction between polysorbate 20 and 80 with human serum albumins and immunoglobulins: A contribution to understand colloidal protein stabilisation
Patrick Garidel et al.
BIOPHYSICAL CHEMISTRY (2009)
Host Cell Proteins in Biologics Development: Identification, Quantitation and Risk Assessment
Xing Wang et al.
BIOTECHNOLOGY AND BIOENGINEERING (2009)
Insights into protein-polysorbate interactions analysed by means of isothermal titration and differential scanning calorimetry
Claudia Hoffmann et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2009)
Surface Activity of a Monoclonal Antibody
Hanns-Christian Mahler et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Polysorbate 20 prevents the precipitation of a monoclonal antibody during shear
Thomas W. Patapoff et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2009)
Non-specific binding and saturation of Polysorbate-20 with aseptic filter membranes for drug substance and drug product during mAb production
Joe X. Zhou et al.
JOURNAL OF MEMBRANE SCIENCE (2008)
Shaken, not stirred: Mechanical stress testing of an IgG1 antibody
Sylvia Kiese et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: Structure and degradation pathways
Bruce A. Kerwin
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Formulation and delivery issues for monoclonal antibody therapeutics
Ann L. Daugherty et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Effects of protein aggregates: An immunologic perspective
Amy S. Rosenberg
AAPS JOURNAL (2006)
Factors influencing the immunogenicity of therapeutic proteins
H Schellekens
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Protein drug stability: A formulation challenge
S Frokjaer et al.
NATURE REVIEWS DRUG DISCOVERY (2005)